Loading...
Loading...
Hansoh Pharmaceutical Group Co Limited/ADR
Hansoh Pharmaceutical Group Co Limited/ADR. Spoken Alpha tracks HNSPF's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks HNSPF's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 90% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for HNSPF.
curl https://api.spokenalpha.com/v1/companies/HNSPF| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $0.58 | $0.46 | +25.6% | -7.3% | -6.5% |
| Q4 FY2026 | $0.66 | $0.49 | +35.5% | -0.1% | +2.3% |
| Q3 FY2026 | $0.54 | $0.41 | +32.6% | -0.9% | +1.1% |
| Q2 FY2026 | $0.60 | $0.44 | +36.2% | -2.0% | -3.0% |
| Q1 FY2025 | $0.79 | $0.57 | +38.4% | -1.3% | -3.8% |
| Q4 FY2025 | $0.59 | $0.48 | +23.7% | -8.8% | -10.5% |
| Q3 FY2025 | $0.68 | $0.50 | +35.8% | -8.4% | -8.4% |
| Q2 FY2025 | $1.00 | $0.75 | +32.7% | -3.8% | -1.5% |
| Q1 FY2024 | $0.93 | $0.71 | +31.5% | -3.6% | -5.5% |
| Q4 FY2024 | $0.92 | $0.72 | +27.7% | +2.3% | +1.6% |